Online Database of Chemicals from Around the World

Dibucaine hydrochloride
[CAS# 61-12-1]

List of Suppliers
Jinan Chenghui-Shuangda Chemical Co., Ltd. China Inquire
www.jnchsd.com
+86 (531) 5889-7051
+86 15053146086
+86 (531) 5889-7093
jnchsd@qq.com
QQ Chat
Chemical manufacturer since 2002
chemBlink Standard supplier since 2007
BOC Sciences USA Inquire
www.bocsci.com
+1 (631) 485-4226
+1 (631) 614-7828
info@bocsci.com
Chemical manufacturer
chemBlink Standard supplier since 2010
Jinan An-dm Chemical Co., Ltd. China Inquire
www.an-dm.com
+86 15550736712
andmchem@hotmail.com
Chemical manufacturer
chemBlink Standard supplier since 2014
Chongqing Land Tower Pharmaceutical Co., Ltd. China Inquire
www.cqlandtower.com
+86 (23) 6898-0308
+86 (23) 6238-5716
business@cqlandtower.com
Chemical manufacturer since 2010
chemBlink Standard supplier since 2014
Hangzhou Leap Chem Co., Ltd. China Inquire
www.leapchem.com
+86 (571) 8771-1850
market19@leapchem.com
QQ Chat
Chemical manufacturer since 2006
chemBlink Standard supplier since 2015
Typu Group China Inquire
www.typugroup.com
+86 85220966
order@typugroup.com
Chemical distributor since 2008
chemBlink Standard supplier since 2021
Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. China Inquire
www.chsdpharma.com
+86-531-58897029
ericqiao@jnchsd.com
QQ Chat
WeChat: 15550412551
WhatsApp:15550412551
Chemical manufacturer since 2014
chemBlink Standard supplier since 2025
Toronto Research Chemicals Inc. Canada Inquire
www.trc-canada.com
+1 (416) 665-9696
+1 (416) 665-4439
info@trc-canada.com
Chemical manufacturer since 1982
Wako Pure Chemical Industries, Ltd. Japan Inquire
www.wako-chem.co.jp
+81 (6) 6203-3741
+81 (6) 6201-5964
wkhk.info@fujifilm.com
Chemical manufacturer since 1922

Identification
ClassificationAPI >> Anesthetic agents >> Local anesthetics
NameDibucaine hydrochloride
Synonyms2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide monohydrochloride; 2-Butoxy-N-(2-diethylaminoethyl)cinchoninamide hydrochloride
Molecular StructureCAS # 61-12-1, Dibucaine hydrochloride
Molecular FormulaC20H29N3O2.HCl
Molecular Weight379.93
CAS Registry Number61-12-1
EC Number200-498-1
SMILESCCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.Cl
Properties
Melting point99 - 101 °C (Expl.)
SolubilityDMSO 76 mg/mL, Water 76 mg/mL (Expl.)
Safety Data
Hazard Symbolssymbol symbol symbol   GHS05;GHS07;GHS09 Danger  Details
Risk StatementsH302-H317-H318-H411  Details
Safety StatementsP261-P264-P264+P265-P270-P272-P273-P280-P301+P317-P302+P352-P305+P354+P338-P317-P321-P330-P333+P317-P362+P364-P391-P501  Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Serious eye damageEye Dam.1H318
Acute toxicityAcute Tox.4H302
Chronic hazardous to the aquatic environmentAquatic Chronic2H411
Skin sensitizationSkin Sens.1H317
Acute toxicityAcute Tox.3H301
Acute toxicityAcute Tox.3H311
Skin irritationSkin Irrit.2H315
Chronic hazardous to the aquatic environmentAquatic Chronic1H410
Acute toxicityAcute Tox.2H330
Specific target organ toxicity - single exposureSTOT SE3H335
Acute hazardous to the aquatic environmentAquatic Acute1H400
SDSAvailable
up Discovery and Applications
Dibucaine hydrochloride is a potent local anesthetic belonging to the amide class of anesthetics. It is primarily used for topical anesthesia of the skin and mucous membranes and occasionally in small doses for spinal anesthesia. Dibucaine hydrochloride exerts its anesthetic effect by blocking voltage-gated sodium channels in nerve cell membranes, thereby inhibiting the initiation and propagation of nerve impulses and causing a reversible loss of sensation in the area of application.

The compound was developed and introduced into clinical use in the mid-20th century, with its chemical structure designed to provide strong and long-lasting local anesthesia. Dibucaine hydrochloride is noted for its high potency compared to other local anesthetics, which makes it effective in very small amounts. It is commonly supplied as a hydrochloride salt to enhance its solubility and stability in aqueous formulations.

Clinically, dibucaine hydrochloride is often used in topical creams, ointments, or solutions for the relief of pain, itching, and discomfort associated with conditions such as hemorrhoids, minor burns, insect bites, and anal fissures. Its use in spinal anesthesia is limited due to concerns about neurotoxicity when used in higher concentrations or volumes.

Pharmacodynamically, dibucaine blocks the conduction of nerve impulses by selectively binding to and stabilizing the inactive state of sodium channels on neuronal membranes. This action prevents the influx of sodium ions necessary for depolarization, effectively blocking nerve signal transmission.

Pharmacokinetically, dibucaine hydrochloride is absorbed slowly from topical sites, which contributes to its prolonged duration of action. When absorbed systemically, it is metabolized primarily in the liver by enzymatic hydrolysis and N-dealkylation pathways. The metabolites and unchanged drug are excreted mainly via the kidneys. The elimination half-life varies depending on the route of administration but is generally several hours.

Adverse effects are primarily related to local irritation or allergic reactions at the site of application. Systemic toxicity is rare but can occur if excessive amounts are absorbed or injected, potentially causing symptoms such as dizziness, tinnitus, nervousness, seizures, or cardiac disturbances. Due to its potency, careful dosing and application are important to avoid toxicity.

Dibucaine hydrochloride is also known for its use in the dibucaine number test, a diagnostic assay to measure atypical plasma cholinesterase activity, which helps identify individuals with genetic variants that affect the metabolism of certain anesthetics.

In summary, dibucaine hydrochloride is a highly potent local anesthetic used primarily for topical pain relief. Its mechanism of action involves sodium channel blockade leading to nerve impulse inhibition. The compound’s strong anesthetic effect, coupled with a relatively slow systemic absorption and metabolism, allows for prolonged local anesthesia with a generally favorable safety profile when used appropriately.

References

1974. Kinetic characteristics of monoamine oxidase and serum cholinesterase in several related rat strains. Biochemical Genetics, 11(4).
DOI: 10.1007/bf00485998

2018. Greenness assessment as per Eco-scale and AMVI metrics for the chromatographic assay of selected drugs in a semisolid dosage form and in tissues. Chemical Papers, 73(3).
DOI: 10.1007/s11696-018-0619-z

2022. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2. The Journal of Biological Chemistry, 298(8).
DOI: 10.1016/j.jbc.2022.102228
Market Analysis Reports
List of Reports Available for Dibucaine hydrochloride
Related Products
alpha,alpha'-Di...  alpha,alpha'-Di...  alpha,alpha'-Di...  2,6-Dibromo-3,4...  Dibromo zinc bi...  Dibromo zinc bi...  Dibrompropamidi...  Dibrompropamidi...  Dibromsalan  Dibromsulphalei...  Dibucaine-d9 Hy...  Dibunate sodium  Dibupyrone  Dibusadol  Dibutanolamine  Dibutanolatobis...  3,6-Dibutanoylm...  [(2R,3R,4R,5S)-...  Dibutanoyl pero...  1,4-Di(Butan-2-...